Clinical Trials for Bicara Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Bicara Therapeutics

Clinical Trials (2)

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

PHASE2/PHASE3Recruiting

650 participants

Started: Jan 28, 2025 · Completed: Jul 31, 2029

2 conditions1 sponsor52 locations

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

PHASE1Recruiting

292 participants

Started: Jun 1, 2020 · Completed: Jun 1, 2027

11 conditions2 sponsors20 locations